Cannabis legalisation is the hot topic of many European politicians, but once the race begins who will be in it to win? Click to read more.
The COVID vaccination changed the face of RNA vaccinations and the effect on the oncology market is set to be huge. Click to find out more.
These revolutionary companies are changing the game when it comes to neurological drug development, and thanks to recent funding they could be on the market sooner than you think. Click to find out more.
While our industry has continued to raise awareness about the lack of diversity within clinical trials, actually addressing the issue remains our biggest challenge. Click to read how some leaders are addressing this.
Bioinformatics is transforming personalised care for cancer and rare diseases and aiding in novel drug discovery. In this article, I wanted to highlight the work and progress being made by some of the top companies in the space.
I come across different exciting companies every day. Each has their own unique story and innovative treatments to match. Click for five companies who’s work you need to know about.
.jpg)
In this clip, I talk about how small companies can beat the larger corporations for talent. They just need to show off what makes them different, that they're people-focused and they can be flexible.
Everyone is talking about Seaspiracy and the environmental impact of commercial fishing. That’s great. This is an important environmental issue that people need to be aware of. But did the film fail to discuss something major?
Every industry ground to a halt in March 2020 as COVID-19 swept the world. While some sectors were forced to shut down completely, clinical trial providers couldn’t simply stop. That would have meant years of research and funding gone to waste.
.jpg)
Diagnostics still has a crucial role to play in combating COVID-19 and, with new funding, a lot of exciting plans too. To find out more, I spoke to Jonathan O’Halloran, who is CEO at QuantuMDx.
Innovative companies are trying to make a real difference for patients with rare diseases and address one of healthcare's largest unmet needs.
.jpg)
There’s optimism throughout all the markets we serve and to celebrate this we asked our CM Life Science team what they think we can expect from the year ahead in life sciences. Here's what they said...
COVID-19 has changed clinical trials forever. To find out how CROs have adapted to the global pandemic and whether this will have a lasting impact on the space, I spoke to two industry leaders.
Prejudice is rife in 2020 (both conscious and unconscious), so it’s crucial that we educate ourselves. It’s never been so important to embrace Black History Month.
.jpg)
The effect of COVID-19 has been huge with thousands of clinical trials interrupted forcing companies and sponsors to adapt. So, they have and the industry may never look the same again.
Animal feed is now responsible for up to 70% of the cost of animal production. To get this figure down and to be more environmentally friendly, the animal market has shifted to sustainable alternatives like additives and different feed sources.
Cytosurge's tiny syringes are a game changer for the single cell genomic and gene editing applications; since patenting the technology in 2009 the company has gone from strength to strength.
In the US alone, a report by the Centers for Disease Control and Prevention (CDC) in March this year highlighted how 2.8 million antibiotic-resistant infections occur each year, leading to the deaths of more than 35,000 people.
Coronavirus has provided us with a very large and extremely recent data set for research, patient populations and how different ethnic minorities are being affected versus the research. And the early indicators are that those from minority background
The approach to fighting coronavirus has not differed to the fight against any other outbreak in terms of what is required to control it.
We’ve been waiting for the $100 genome for a long time and now it’s here. Check out what our consultants had to say about this big news and other landmark announcements at AGBT 2020.
There’s so much more to the UK biotech scene than just London and Cambridge. In the North, we're surrounded by many fascinating companies who’re innovating and conducting crucial research.
.png)
Decentralised, virtual, home, remote… whatever the name of this type of trial, it's widely agreed they will be crucial to advancing healthcare.
.png)
Connectivity is the future for labs, bringing countless benefits. Check out the forward-thinking companies leading this technology trend.
.png)
The race is on to get CRISPR into diagnostics. This would bring countless benefits including quicker and more accurate results for both infectious and non-infectious disease.
.png)
Heading into the proactive world of personalised care, data insights are providing us with more effective, targeted and preventative treatments for patients.
A new generation of start-ups are revolutionising cancer diagnosis, detecting disease before patients even show symptoms with liquid biopsy tests. This innovation is rife in the US.
Globally, sepsis takes six million lives each year. It causes more deaths than breast cancer, lung cancer and stroke combined. Here are five diagnostics companies combating this ugly statistic.
I’ve lost count of the times I’ve seen ‘PhD preferred’, while recruiting for positions in R&D and product development. In the modern life science talent market, are PhDs really so important?
With a new home, the Minicare I-20 will cement its place as the market leader. As always, this extra competition will encourage innovation among competitors.
